Psychedelic harm reduction applies the public health approach of harm reduction to psychedelics: information, services and practices that aim to lower the health, social and legal harms of use, without making abstinence a condition of help. It mostly serves people who use psychedelics outside clinical settings. It is an approach to risk, not a treatment or an endorsement of use.
Where the idea comes from
Harm reduction services include needle and syringe programs and overdose prevention. Harm Reduction International describes it as policies, programs and practices that aim to minimize the negative effects of drug use and of drug laws, working with people without judgment and without requiring them to stop. In mental health care, a 2021 clinical model applies the same stance to therapy with people who use or are considering psychedelics in any context, and therapists can meet clients before and after their own psychedelic experiences while staying within the law.
What it includes
Typical elements are accurate information about effects and interactions, drug checking, support during and after difficult experiences, and help with integration. Evidence for these practices is thin: a 2025 scoping review found 27 relevant papers but only four that tested an intervention, and noted low use of drug-checking services. In one survey of 163 people, using more such practices went with less challenging experiences. Among the 19 people in a global survey who sought emergency care after taking mushrooms, the reasons given most often were the wrong mindset (47 percent), the wrong place and mixing substances (37 percent each). And among 1,993 people recalling their worst mushroom experience, only 2.7 percent had a sober, experienced guide present.
What it does not do
What a product contains is often unknown: in 2024 the FDA traced 180 illnesses in 34 states, including 73 hospitalizations, to one brand of mushroom-branded chocolates and gummies, and the NIH warns that some poisonous mushrooms look like psilocybin species. Harm reduction does not make use legal or replace medical screening. The questions in our retreat checklist apply to any provider, us included.
Related terms
Set and Setting: the expectations and surroundings that most advice focuses on.
Challenging Psychedelic Experience: the difficult states harm reduction tries to prepare for.
Psychedelic Integration: making sense of an experience in the weeks after it.
Sources
Harm Reduction International - What is harm reduction? (definition and core services)
Pilecki, Luoma, Bathje, Rhea & Narloch - Ethical and legal issues in psychedelic harm reduction and integration therapy, Harm Reduction Journal, 2021 (therapists’ legal and ethical limits)
Dutton, North, Chun Tie, Oliva & Skeffington - Harm reduction practises for users of psychedelic drugs: A scoping review, Harm Reduction Journal, 2025 (27 papers, four intervention studies)
Palmer & Maynard - Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience, Harm Reduction Journal, 2022 (163 participants)
Kopra, Ferris, Winstock, Young & Rucker - Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms, Journal of Psychopharmacology, 2022 (reasons for incidents)
Carbonaro et al. - Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences, Journal of Psychopharmacology, 2016 (guides and sitters)
US Food and Drug Administration - Investigation of illnesses: Diamond Shruumz-brand chocolate bars, cones and gummies, 2024 (180 illnesses in 34 states)
National Center for Complementary and Integrative Health - Psilocybin for Mental Health and Addiction: What You Need To Know, 2024 (poisonous look-alike mushrooms)